Nathan was diagnosed with Angelman Syndrome (AS) in 2014 at the age of 28 months. Since that day our love for Nathan has grown tenfold. He’s the most happy, loving, and determined little boy we’ve ever met! Even through seizures, endless doctor & therapy appointments, and all the other symptoms that come along with AS he continues to work hard every day to keep up with his two siblings.
Angelman Syndrome (AS) is a rare neurogenetic disorder affecting approximately 1 in 15,000 live births. Individuals with AS typically have balance issues, motor impairment and debilitating seizures. Some patients never walk and most do not speak. Despite its often devastating effects, AS is a simple disorder involving only one gene. The Foundation for Angelman Syndrome Therapeutics (FAST) scientists have already cured AS in the lab using several different approaches. FAST is committed to bringing life-changing treatments for AS to clinical trial within two years, but we need your help!
FAST has brought together a multi-disciplined team of more than two-dozen scientists from multiple universities and pharmaceutical companies to join forces on a focused path to a cure. Their work will change life for people with AS and potentially related disorders, like Autism and Alzheimer’s Disease. FAST is the largest non-governmental funder of AS research and the only organization with a detailed plan towards a cure.
Thank you in advance for your generosity, it means a lot!!
Andrew & Kaline Gillespie